Brian Tanquilut
Stock Analyst at Jefferies
(4.19)
# 476
Out of 5,116 analysts
136
Total ratings
62.24%
Success rate
10.9%
Average return
Main Sectors:
Stocks Rated by Brian Tanquilut
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare | Maintains: Buy | $485 → $525 | $477.13 | +10.03% | 9 | Oct 28, 2025 | |
| AVAH Aveanna Healthcare Holdings | Maintains: Buy | $11 → $13 | $8.62 | +45.01% | 4 | Oct 28, 2025 | |
| PNTG The Pennant Group | Initiates: Buy | $30 | $29.05 | +3.27% | 1 | Oct 24, 2025 | |
| MCK McKesson | Maintains: Buy | $820 → $900 | $828.26 | +8.66% | 4 | Oct 14, 2025 | |
| ODD Oddity Tech | Initiates: Buy | $78 | $41.92 | +86.07% | 1 | Sep 24, 2025 | |
| CHE Chemed | Upgrades: Buy | $490 → $550 | $432.18 | +27.26% | 2 | Sep 2, 2025 | |
| CYH Community Health Systems | Downgrades: Hold | $4.25 → $3 | $3.23 | -7.12% | 10 | Jul 24, 2025 | |
| CVS CVS Health | Maintains: Buy | $74 → $80 | $79.61 | +0.49% | 14 | Jun 30, 2025 | |
| CAH Cardinal Health | Upgrades: Buy | $140 → $150 | $208.29 | -27.99% | 4 | Feb 5, 2025 | |
| OPCH Option Care Health | Upgrades: Buy | $26 → $35 | $32.58 | +7.43% | 4 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $80 | $73.15 | +9.36% | 8 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8.25 → $9.5 | $9.38 | +1.28% | 4 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $41 → $27 | $16.10 | +67.70% | 5 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $10.89 | -26.54% | 9 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $245 → $265 | $253.89 | +4.38% | 6 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $9 | $7.13 | +26.23% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $21.87 | -58.85% | 10 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $37.75 | -52.32% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $140 → $155 | $175.94 | -11.90% | 6 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $85 | $200.60 | -57.63% | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $32 → $21 | $8.00 | +162.50% | 4 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $8.5 → $14 | $19.63 | -28.68% | 6 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $28.00 | +60.71% | 1 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.64 | +174.73% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $24.13 | +36.76% | 1 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $0.73 | +4,722.27% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $110.16 | -31.92% | 1 | Aug 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $47 | $14.69 | +219.95% | 5 | Jul 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $13 | $15.87 | -18.08% | 2 | Nov 1, 2017 |
HCA Healthcare
Oct 28, 2025
Maintains: Buy
Price Target: $485 → $525
Current: $477.13
Upside: +10.03%
Aveanna Healthcare Holdings
Oct 28, 2025
Maintains: Buy
Price Target: $11 → $13
Current: $8.62
Upside: +45.01%
The Pennant Group
Oct 24, 2025
Initiates: Buy
Price Target: $30
Current: $29.05
Upside: +3.27%
McKesson
Oct 14, 2025
Maintains: Buy
Price Target: $820 → $900
Current: $828.26
Upside: +8.66%
Oddity Tech
Sep 24, 2025
Initiates: Buy
Price Target: $78
Current: $41.92
Upside: +86.07%
Chemed
Sep 2, 2025
Upgrades: Buy
Price Target: $490 → $550
Current: $432.18
Upside: +27.26%
Community Health Systems
Jul 24, 2025
Downgrades: Hold
Price Target: $4.25 → $3
Current: $3.23
Upside: -7.12%
CVS Health
Jun 30, 2025
Maintains: Buy
Price Target: $74 → $80
Current: $79.61
Upside: +0.49%
Cardinal Health
Feb 5, 2025
Upgrades: Buy
Price Target: $140 → $150
Current: $208.29
Upside: -27.99%
Option Care Health
Jan 23, 2025
Upgrades: Buy
Price Target: $26 → $35
Current: $32.58
Upside: +7.43%
Jan 15, 2025
Maintains: Buy
Price Target: $100 → $80
Current: $73.15
Upside: +9.36%
Dec 9, 2024
Upgrades: Buy
Price Target: $8.25 → $9.5
Current: $9.38
Upside: +1.28%
Nov 13, 2024
Maintains: Hold
Price Target: $41 → $27
Current: $16.10
Upside: +67.70%
Oct 16, 2024
Initiates: Buy
Price Target: $8
Current: $10.89
Upside: -26.54%
Sep 23, 2024
Maintains: Buy
Price Target: $245 → $265
Current: $253.89
Upside: +4.38%
Mar 6, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $7.13
Upside: +26.23%
Mar 6, 2024
Maintains: Hold
Price Target: $10 → $9
Current: $21.87
Upside: -58.85%
Feb 20, 2024
Initiates: Buy
Price Target: $18
Current: $37.75
Upside: -52.32%
Feb 7, 2024
Upgrades: Buy
Price Target: $140 → $155
Current: $175.94
Upside: -11.90%
Nov 14, 2023
Maintains: Buy
Price Target: $95 → $85
Current: $200.60
Upside: -57.63%
Nov 3, 2023
Downgrades: Hold
Price Target: $32 → $21
Current: $8.00
Upside: +162.50%
Mar 24, 2023
Upgrades: Hold
Price Target: $8.5 → $14
Current: $19.63
Upside: -28.68%
Nov 7, 2022
Assumes: Buy
Price Target: $45
Current: $28.00
Upside: +60.71%
Aug 15, 2022
Initiates: Buy
Price Target: $10
Current: $3.64
Upside: +174.73%
Jan 3, 2022
Initiates: Buy
Price Target: $33
Current: $24.13
Upside: +36.76%
Oct 20, 2021
Initiates: Buy
Price Target: $35
Current: $0.73
Upside: +4,722.27%
Aug 21, 2018
Initiates: Buy
Price Target: $75
Current: $110.16
Upside: -31.92%
Jul 31, 2018
Maintains: Buy
Price Target: $44 → $47
Current: $14.69
Upside: +219.95%
Nov 1, 2017
Maintains: Buy
Price Target: $16 → $13
Current: $15.87
Upside: -18.08%